ANIXA BIOSCIENCES, INC. (ANIX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
20/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseANIX / S&P 8.53% / 15.20% |
LoseANIX / S&P ANIX unavailable / 15.00% |
LoseANIX / S&P -18.42% / 50.40% |
| 2026-Q10/3 |
LoseANIX / S&P -17.31% / -4.33% |
LoseANIX / S&P ANIX unavailable / 11.30% |
LoseANIX / S&P -15.38% / 27.70% |
| 2025-Q40/3 |
LoseANIX / S&P -5.45% / 2.65% |
LoseANIX / S&P ANIX unavailable / 9.00% |
LoseANIX / S&P -10.26% / 13.40% |
| 2025-Q30/3 |
LoseANIX / S&P 0.00% / 8.12% |
LoseANIX / S&P ANIX unavailable / 4.61% |
LoseANIX / S&P -10.26% / 13.45% |
| 2025-Q21/3 |
WinANIX / S&P 15.38% / 10.94% |
LoseANIX / S&P ANIX unavailable / 4.83% |
LoseANIX / S&P 2.70% / 10.63% |
| 2025-Q12/3 |
WinANIX / S&P 23.28% / -4.27% |
LoseANIX / S&P ANIX unavailable / 4.98% |
WinANIX / S&P 14.71% / 10.57% |
| 2024-Q41/3 |
LoseANIX / S&P -26.35% / 2.41% |
LoseANIX / S&P ANIX unavailable / 5.25% |
WinANIX / S&P 143.75% / 6.15% |
| 2024-Q31/3 |
WinANIX / S&P 42.53% / 5.89% |
LoseANIX / S&P ANIX unavailable / 5.89% |
LoseANIX / S&P -154.93% / 6.11% |
| 2024-Q20/3 |
LoseANIX / S&P -29.17% / 4.28% |
LoseANIX / S&P ANIX unavailable / 5.38% |
LoseANIX / S&P -152.86% / 5.12% |
| 2024-Q10/3 |
LoseANIX / S&P -19.59% / 10.56% |
LoseANIX / S&P ANIX unavailable / 5.71% |
LoseANIX / S&P ANIX unavailable / 5.59% |
| 2023-Q41/3 |
WinANIX / S&P 18.65% / 11.69% |
LoseANIX / S&P ANIX unavailable / 6.81% |
LoseANIX / S&P ANIX unavailable / 7.78% |
| 2023-Q31/3 |
WinANIX / S&P 2.19% / -3.27% |
LoseANIX / S&P ANIX unavailable / 7.52% |
LoseANIX / S&P ANIX unavailable / -5.03% |
| 2023-Q20/3 |
LoseANIX / S&P -25.58% / 8.74% |
LoseANIX / S&P ANIX unavailable / 9.50% |
LoseANIX / S&P ANIX unavailable / -8.57% |
| 2023-Q10/3 |
LoseANIX / S&P 1.18% / 7.50% |
LoseANIX / S&P ANIX unavailable / 10.77% |
LoseANIX / S&P ANIX unavailable / -15.69% |
| 2022-Q40/3 |
LoseANIX / S&P -13.62% / 7.56% |
LoseANIX / S&P ANIX unavailable / 11.88% |
LoseANIX / S&P ANIX unavailable / -17.99% |
| 2022-Q31/3 |
WinANIX / S&P 60.78% / -4.88% |
LoseANIX / S&P ANIX unavailable / 13.47% |
LoseANIX / S&P ANIX unavailable / -1.41% |
| 2022-Q21/3 |
WinANIX / S&P 11.68% / -16.10% |
LoseANIX / S&P ANIX unavailable / 13.71% |
LoseANIX / S&P ANIX unavailable / 11.04% |
| 2022-Q10/3 |
LoseANIX / S&P -7.74% / -4.60% |
LoseANIX / S&P ANIX unavailable / 15.97% |
LoseANIX / S&P ANIX unavailable / 42.23% |
| 2021-Q40/3 |
LoseANIX / S&P -37.74% / 11.03% |
LoseANIX / S&P ANIX unavailable / 15.00% |
LoseANIX / S&P ANIX unavailable / 96.40% |
| 2021-Q31/3 |
WinANIX / S&P 22.94% / 0.58% |
LoseANIX / S&P ANIX unavailable / 10.77% |
LoseANIX / S&P ANIX unavailable / 69.42% |
| 2021-Q20/3 |
LoseANIX / S&P -17.09% / 8.55% |
LoseANIX / S&P ANIX unavailable / 6.58% |
LoseANIX / S&P ANIX unavailable / 51.81% |
| 2021-Q11/3 |
WinANIX / S&P 52.44% / 6.17% |
LoseANIX / S&P ANIX unavailable / -1.06% |
LoseANIX / S&P ANIX unavailable / 7.39% |
| 2020-Q41/3 |
WinANIX / S&P 26.34% / 12.15% |
LoseANIX / S&P ANIX unavailable / -3.72% |
LoseANIX / S&P ANIX unavailable / -33.42% |
| 2020-Q30/3 |
LoseANIX / S&P -20.59% / 8.93% |
LoseANIX / S&P ANIX unavailable / -2.04% |
LoseANIX / S&P ANIX unavailable / -27.10% |
| 2020-Q21/3 |
WinANIX / S&P 92.45% / 20.54% |
LoseANIX / S&P ANIX unavailable / -0.46% |
LoseANIX / S&P ANIX unavailable / -27.11% |
| 2020-Q10/3 |
LoseANIX / S&P -51.52% / -19.60% |
LoseANIX / S&P ANIX unavailable / 3.47% |
LoseANIX / S&P ANIX unavailable / -14.75% |
| 2019-Q40/3 |
LoseANIX / S&P -18.00% / 9.07% |
LoseANIX / S&P ANIX unavailable / 5.36% |
LoseANIX / S&P ANIX unavailable / 2.99% |
| 2019-Q31/3 |
WinANIX / S&P 10.19% / 1.70% |
LoseANIX / S&P ANIX unavailable / 5.02% |
LoseANIX / S&P ANIX unavailable / 0.21% |
| 2019-Q20/3 |
LoseANIX / S&P -19.69% / 4.30% |
LoseANIX / S&P ANIX unavailable / 6.64% |
LoseANIX / S&P ANIX unavailable / 8.65% |
| 2019-Q11/3 |
WinANIX / S&P 14.72% / 13.65% |
LoseANIX / S&P ANIX unavailable / 8.12% |
LoseANIX / S&P ANIX unavailable / 14.29% |
| 2018-Q40/3 |
LoseANIX / S&P -15.09% / -13.52% |
LoseANIX / S&P ANIX unavailable / 9.05% |
LoseANIX / S&P ANIX unavailable / 18.23% |
| 2018-Q31/3 |
WinANIX / S&P 53.14% / 7.71% |
LoseANIX / S&P ANIX unavailable / 10.21% |
LoseANIX / S&P ANIX unavailable / 19.06% |
| 2018-Q20/3 |
LoseANIX / S&P -21.09% / 3.43% |
LoseANIX / S&P ANIX unavailable / 9.03% |
LoseANIX / S&P ANIX unavailable / 14.46% |
| 2018-Q11/3 |
WinANIX / S&P 62.71% / -0.76% |
LoseANIX / S&P ANIX unavailable / 7.68% |
LoseANIX / S&P ANIX unavailable / 12.46% |
| 2017-Q40/3 |
LoseANIX / S&P -10.27% / 6.64% |
LoseANIX / S&P ANIX unavailable / 7.03% |
LoseANIX / S&P ANIX unavailable / 13.82% |
| 2017-Q31/3 |
WinANIX / S&P 128.70% / 4.48% |
LoseANIX / S&P ANIX unavailable / 5.68% |
LoseANIX / S&P ANIX unavailable / 17.57% |
| 2017-Q20/3 |
LoseANIX / S&P -61.67% / 3.09% |
LoseANIX / S&P ANIX unavailable / 4.83% |
LoseANIX / S&P ANIX unavailable / 17.74% |
| 2017-Q10/3 |
LoseANIX / S&P -44.44% / 6.07% |
LoseANIX / S&P ANIX unavailable / 3.67% |
LoseANIX / S&P ANIX unavailable / 13.32% |
| 2016-Q41/3 |
WinANIX / S&P 38.82% / 3.82% |
LoseANIX / S&P ANIX unavailable / 2.09% |
LoseANIX / S&P ANIX unavailable / 7.05% |
| 2016-Q31/3 |
WinANIX / S&P 23.89% / 3.85% |
LoseANIX / S&P ANIX unavailable / 0.20% |
LoseANIX / S&P ANIX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ANIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 20.40% | 20.78% |
| Annualized return | 20.40% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ANIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -32.20% | 83.14% |
| Annualized return | -7.48% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ANIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -6.74% | 319.30% |
| Annualized return | -0.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |